GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » EV-to-EBIT

Forian (Forian) EV-to-EBIT : 15.82 (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Forian EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Forian's Enterprise Value is $59.38 Mil. Forian's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $3.75 Mil. Therefore, Forian's EV-to-EBIT for today is 15.82.

The historical rank and industry rank for Forian's EV-to-EBIT or its related term are showing as below:

FORA' s EV-to-EBIT Range Over the Past 10 Years
Min: -90.92   Med: -6.52   Max: 64.07
Current: 15.82

During the past 5 years, the highest EV-to-EBIT of Forian was 64.07. The lowest was -90.92. And the median was -6.52.

FORA's EV-to-EBIT is ranked better than
56.1% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 18.15 vs FORA: 15.82

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Forian's Enterprise Value for the quarter that ended in Mar. 2024 was $79.78 Mil. Forian's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $3.75 Mil. Forian's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.71%.


Forian EV-to-EBIT Historical Data

The historical data trend for Forian's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian EV-to-EBIT Chart

Forian Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -10.71 -5.07 25.24

Forian Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.64 -8.77 39.42 25.24 21.25

Competitive Comparison of Forian's EV-to-EBIT

For the Health Information Services subindustry, Forian's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forian's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Forian's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Forian's EV-to-EBIT falls into.



Forian EV-to-EBIT Calculation

Forian's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=59.384/3.754
=15.82

Forian's current Enterprise Value is $59.38 Mil.
Forian's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forian  (NAS:FORA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Forian's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=3.754/79.781424
=4.71 %

Forian's Enterprise Value for the quarter that ended in Mar. 2024 was $79.78 Mil.
Forian's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forian EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Forian's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Forian (Forian) Business Description

Traded in Other Exchanges
N/A
Address
41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.
Executives
Martin J Wygod director P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr director
Max C Wygod director, officer: Executive Chairman 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust 10 percent owner 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey officer: Chief Financial Officer 4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori director C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur director C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr officer: Chief Financial Officer C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md director
Ian Banwell director P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin director, officer: Chief Strategy Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton director, officer: Chief Executive Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940

Forian (Forian) Headlines

From GuruFocus

Forian Inc. Set to Join Russell 3000� Index

By PRNewswire PRNewswire 06-07-2021

Forian Announces the Sale of BioTrack to Alleaves

By sperokesalga sperokesalga 02-13-2023

Forian Inc. to Announce 2022 Third Quarter Results on November 14, 2022

By GlobeNewswire GlobeNewswire 10-31-2022

Forian Inc. to Announce 2022 Third Quarter Results on November 14, 2022

By Value_Insider Value_Insider 10-31-2022

Forian Inc. to Present at 34th Annual Roth Conference

By GuruFocusNews GuruFocusNews 03-10-2022